Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 133 member H, pseudogene (FAM133HP) is classified as a human pseudogene. Pseudogenes are segments of DNA that resemble functional genes but typically are non-coding due to mutations or loss of regulatory elements. Many pseudogenes are transcribed; their RNA transcripts can play regulatory roles, such as modulating gene expression by acting as microRNA sponges, generating short interfering RNAs, or affecting the stability of mRNAs of their parent (protein-coding) genes. However, FAM133HP is not recognized as encoding a functional protein, receptor, enzyme, or other characterized therapeutic target and has no established role as a disease biomarker or drug target. Any biological or disease relevance attributed to FAM133HP would be speculative or extrapolated from general pseudogene functions[1][2][5]. In summary, this entity is a pseudogene—not a canonical therapeutic target or protein—but pseudogenes as a class can have emerging biological roles at the RNA level[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 133 member H, pseudogene (FAM133HP).